APA citiranje

Wang, C., Delogu, S., Ho, C., Lee, S. A., Gui, B., Jiang, L., . . . Chen, X. (2012). Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways.

Citação norma Chicago

Wang, Chunmei, et al. Inactivation of Spry2 Accelerates AKT-driven Hepatocarcinogenesis Via Activation of MAPK and PKM2 Pathways. 2012.

MLA citiranje

Wang, Chunmei, et al. Inactivation of Spry2 Accelerates AKT-driven Hepatocarcinogenesis Via Activation of MAPK and PKM2 Pathways. 2012.